KELLEY COCHRAN: Open Payments
NPI 1528149895 · PAINTSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 22 payments from 10 companies in 2025. Trend: 2023 $445 · 2024 $542 · 2025 $390
Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $124 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $67 |
| ABBVIE INC. | 2 | $47 |
| Ardelyx, Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| SHIELD THERAPEUTICS INC | 1 | $19 |
| Amgen Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
Products named: LEQVIO, Kerendia, UBRELVY, IBSRELA, TRINTELLIX, INSPIRE, ACCRUFER, EVENITY.
Industry payments across KY — which companies pay providers there.
